This Feasibility study is trying to determine: * If Lymphoscintigraphy (imaging of the lymphatic drainage patterns) is effective in demonstrating the drainage…

Breast CancerInflammatory Breast CancerSentinel Lymph Node

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT04636710

Phase 2

TRUDI: A Phase II Study of Neoadjuvant Trastuzumab Deruxtecan and Durvalumab for Stage III, HER2-expressing Inflammatory Breast Cancer

The purpose of this study is to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn wheth…

Invasive Breast CancerInflammatory Breast Cancer Stage IIIHER2-positive Breast Cancer+2 more

~Estimated

~$10 – $7,500

Filipa Lynce, MDNCT05795101